RSS

AstraZeneca

Diagnostics company, Owlstone Medical, has signed a service agreement with global biopharmaceutical company, AstraZeneca, to explore how breath can be used to identify novel biomarkers for personalised medicine applications. more

News

Karolinska Institute spin out company, Pelago Bioscience, has entered into a strategic research collaboration and licence agreement with AstraZeneca for the further advancement of the CETSA method and its use in pre-clinical discovery more

News

The US FDA has expanded its approval of Imfinzi (durvalumab) to now include the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumours are unresectable and have not progressed after chemoradiation treatment. more

News

The collaboration between AstraZeneca and TissUse is progressing with the establishment of relevant microphysiological system (MPS) models based on TissUse’s multi-organ-chip technology, the companies announced. more

Technology

A ceremony has been held in Sweden marking the start of a long-term manufacturing agreement between Cambrex — manufacturer of small molecule innovator and active pharmaceutical ingredients — and AstraZeneca. more

News

Researchers from Cardiff University, in collaboration with Liverpool John Moores University and AstraZeneca, have developed a new tool to assess the likelihood of a drug undergoing racemisation once inside the body. more

Technology

Alderley Park has been confirmed as the interim home for the Cancer Research UK (CRUK) Manchester Institute, underlining it as a key asset in the North of England. more

News

The US Food and Drug Administration (FDA) has accepted and granted priority review of a supplemental new drug application (sNDA) for Lynparza to be used in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer. more

News

The House of Lords Science and Technology Committee will hear evidence from pharmaceutical companies, including AstraZeneca and GlaxoSmithKline (GSK), this week in its continued inquiry into the life sciences and industrial strategy. more

News

AstraZeneca has extended its contract with logistics provider, Yusen Logistics, for the global distribution of its products. more

News

A collaboration has been announced between AstraZeneca and Takeda Pharmaceutical Company for the development and commercialisation of an alpha-synuclein antibody, MEDI1341, as a potential treatment for Parkinson’s disease. more

News

Following disappointing announcements this week concerning the unmet primary endpoints of their Phase III trials, Merck and AstraZeneca have today revealed they are entering a strategic oncology collaboration. more

News

A quick review of some recent treatment approvals, clinical studies and general news in curing diseases, affecting patients from top to bottom. more

News

According to Lord Prior of Brampton, the life sciences sector has the potential to be number one in the UK. more

News

Pharmaceutical company AstraZeneca has turned to a patient data capture start-up to help aid clinical trials. more

News

Biopharmaceutical company, AstraZeneca has unveiled its NiCola-B drug discovery robot, capable of performing industrial scale experiments in the search for new, life-saving medicines. more

News

Pharmaceutical company AstraZeneca has announced that it will be transferring certain UK based office jobs outside of the country to cut costs. more

News

A drug that can lead to the reduction in lung cancer tumours has been made available on the NHS. more

News

The Milner Therapeutics Consortium (Milner), the outreach programme of the Milner Therapeutics Institute, has announced Japanese pharmaceutical company Shionogi, as the new partner joining the consortium more

News

Innovation – it’s everywhere in the pharmaceutical sector. Sometimes it’s a small step but more often it's continued effort into drug development, delivery or research that leads to the constant stream of new products and formulations more

News